Thiazide diuretics: all 264 studies that test it

Page 3 of 3. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting ConditionsCompletedNCT00778726Not applicable
• Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed ConditionsCompletedNCT00778674Not applicable
• Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting ConditionsCompletedNCT00776646Not applicable
• Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.CompletedNCT00775814Phase 4
• Regression of Fatty Heart by Valsartan TherapyWithdrawnNCT00745953Phase 4
• A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideCompletedNCT00671424Phase 1
• Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive PatientsCompletedNCT00670566Phase 4
• Fasting Study of Metolazone Tablets 10 mg and Zaroloxyn® Tablets 10 mgCompletedNCT00650195Phase 1
• Fasting Study of Hydrochlorothiazide Tablets 50 mg to Hydrochlorothiazide Tablets 50 mgCompletedNCT00649324Early Phase 1
• Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mgCompletedNCT00649181Phase 1
• Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mgCompletedNCT00649051Phase 1
• Factorial Study of Metoprolol Succinate TOPROL-XL (324A)CompletedNCT00642096Phase 3
• Dose-Dependent Effect of Thiazide in Dent's Disease HypercalciuriaTerminatedNCT00638482Phase 2/3
• Antihypertensive Response to Losartan and Genetic PolymorphismsCompletedNCT00617877Not applicable
• The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE)CompletedNCT00607035Phase 4
• Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With HypertensionCompletedNCT00548067Phase 3
• Pathophysiological Mechanisms of Hypertensive LVH:Optimising RegressionCompletedNCT00518479Not applicable
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on AmlodipineCompletedNCT00509470Phase 4
• Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate HypertensionCompletedNCT00500604Phase 4
• Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 MonthsCompletedNCT00487123Phase 4
• Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingCompletedNCT00443612Phase 4
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive PatientsCompletedNCT00426478Phase 4
• Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients HypertensionCompletedNCT00425997Phase 4
• Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina PectorisTerminatedNCT00424801Not applicable
• Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in HypertensionCompletedNCT00400777Phase 4
• Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic SubjectsTerminatedNCT00388388Phase 2
• Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and ProteinuriaSuspendedNCT00369538Phase 4
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00367094Phase 3
• Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus HydrochlorothiazideCompletedNCT00360178Phase 3
• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential HypertensionCompletedNCT00355589Phase 3
• Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)CompletedNCT00338936Phase 3
• 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe HypertensionCompletedNCT00327587Phase 3
• A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)CompletedNCT00311740Phase 3
• Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and PlaceboCompletedNCT00282178Phase 2
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00280540Phase 4
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00277472Phase 4
• PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT00274638Phase 4
• Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe HypertensionCompletedNCT00273299Phase 3
• Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)CompletedNCT00263393Phase 4
• Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate HypertensionCompletedNCT00263003Phase 3
• Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionCompletedNCT00257491Phase 3
• A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.CompletedNCT00250562Phase 3
• Behavioural Treatment of HypertensionCompletedNCT00247910Not applicable
• A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With HypertensionCompletedNCT00241007Phase 3
• PHARES Study: Management of Resistant HypertensionCompletedNCT00224549Phase 4
• Olmesartan in Essential HypertensionCompletedNCT00185172Phase 3
• Hypertension and Cardiovascular Risk FactorsCompletedNCT00171782Phase 4
• Antialbuminuric Effects of Valsartan and LisinoprilTerminatedNCT00171600Phase 4
• Antiproteinuric Effect of Valsartan and LisinoprilCompletedNCT00171574Phase 4
• Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.CompletedNCT00171561Phase 4
• VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan MedoxomilCompletedNCT00171015Phase 3
• Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170989Phase 3
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic SyndromeCompletedNCT00170937Phase 4
• Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesCompletedNCT00160160Not applicable
• 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00153049Phase 2
• Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mgCompletedNCT00146341Phase 3
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential HypertensionCompletedNCT00139698Phase 3
• Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive PatientsCompletedNCT00135551Phase 4
• INVEST: INternational VErapamil SR Trandolapril STudyCompletedNCT00133692Phase 4
• Diuretics In the Management of Essential Hypertension (DIME) StudyCompletedNCT00131846Phase 4
• IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering DrugsCompletedNCT00128518Phase 4
• The Hypertension in the Very Elderly Trial (HYVET)Status unknownNCT00122811Phase 4
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionCompletedNCT00095550Phase 3
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionCompletedNCT00095394Phase 3

← Thiazide diuretics overview